3'UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma.

Background: is a prognostic marker and a potential predictive biomarker for radioresistance in head and neck tumors. Its overexpression has been associated with promoter methylation and a worse prognosis in oral squamous cell carcinoma (OSCC) patients. However, opposite outcomes are also described.